XML 56 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
SEGMENT AND GEOGRAPHIC INFORMATION
 9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC INFORMATION
SEGMENT AND GEOGRAPHIC INFORMATION

In the first quarter of 2015, the Company began to disclose three global reportable segments as a result of changes in how the Company internally manages and reports the results of its businesses to its chief operating decision maker. On July 1, 2015, the Company completed the separation of its spine business, which was a reportable segment. See Note 2 - Discontinued Operations for additional information. Following the separation, the Company is disclosing two reportable segments. The two reportable segments and their activities are described below:

•
The Specialty Surgical Solutions segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and Neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.
•
The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts and nerve and tendon repair.

The most notable change from the Company's financial statements for the year ended December 31, 2014 included in the Annual Report on Form 10-K is the integration of the former International reportable segment into the segments noted above as well as certain products from the Private Label segment into Orthopedics and Tissue Technologies and Spine. The Spine Private Label products were included in the separation of the spine business.

The Corporate and other category includes (i) various legal, finance, information systems, executive, and human resource functions, (ii) brand management, and (iii) share-based compensation costs. Prior to the realignment, costs related to procurement, manufacturing operations and logistics for the Company's entire organization were not allocated to operating segments. In connection with the realignment, a portion of these costs have now been incorporated into the disclosed operating segments.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the three and nine months ended September 30, 2015 and 2014 are as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
 
(In thousands)
Segment Net Sales
 
 
 
 
 
 
 
Specialty Surgical Solutions
$
147,085

 
$
137,494

 
$
433,834

 
$
402,210

Orthopedics and Tissue Technologies
79,282

 
60,029

 
207,740

 
175,433

Total revenues
$
226,367

 
$
197,523

 
$
641,574

 
$
577,643

Segment Profit
 
 
 
 
 
 
 
Specialty Surgical Solutions
$
61,017

 
$
54,406

 
$
183,674

 
$
151,694

Orthopedics and Tissue Technologies
20,072

 
20,812

 
59,095

 
59,354

Segment profit
81,089

 
75,218

 
242,769

 
211,048

Amortization
(2,942
)
 
(1,598)

 
(6,418)

 
(4,839)

Corporate and other
(68,153
)
 
(56,513
)
 
(180,772)

 
(167,933
)
Operating income from continuing operations
$
9,994

 
$
17,107

 
$
55,579

 
$
38,276



The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
 
(In thousands)
United States
$
178,290

 
$
150,867

 
$
493,559

 
$
433,865

Europe
24,275

 
22,369

 
75,046

 
70,207

Rest of World
23,802

 
24,287

 
72,969

 
73,571

Total Revenues
$
226,367

 
$
197,523

 
$
641,574

 
$
577,643